GSK starts $2.6B HGSI bid; HGSI will respond in 10 business days

GlaxoSmithKline‘s (NYSE:GSK) forced Human Genome Sciences’ (NASDAQ:HGSI) hand and now the biotechnology company must make a decision about its future on a much faster timetable than it wou…
Read the full story: MedCity News